Clinical Trial Update: Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating tofacitinib for rheumatoid arthritis-related interstitial lung disease (RA-ILD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: National Institute of Respiratory Diseases, Mexico | Conditions: Rheumatoid Arthritis, Interstitial Lung Disease | Phase 2 | Status: UNKNOWN